Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Julie Toplin(SunEdison (United States)), Chad Galderisi(Center for Cancer and Blood Disorders), Kevin Hawkins(SunEdison (United States)), Staci McAdams, Clark C. Fjeld(SunEdison (United States)), Jonathan Eibl(SunEdison (United States)), Kristy Drafahl(SunEdison (United States)), Thomas D. Yager(FedEx (United States))
Blood
November 15, 2013
Cited by 2


Related Papers